ArticleBreast cancer (Tokyo, Japan)2025

Pembrolizumab added to neoadjuvant chemotherapy may improve pathological complete response in androgen-receptor positive and low tumor-infiltrating lymphocytes triple-negative breast cancer patients.

No numbers read from the abstract.

Not cited yet